Healthcare -
Biotechnology - NASDAQ - US
$ 1.215
-12.3 %
$ 86.5 M
Market Cap
-0.61
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Ventyx Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 148 M |
| Operating Income | -148 M |
| Other Expenses | -13.3 M |
| Net Income | -135 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0.9 | 0.5 | 30 K | 0 | 0 |
| Gross Profit | 0 | (0.9) | (0.5) | 30 K | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 148.4 | 208.0 | 113.1 | 67.1 | 7.0 | 4.2 |
| Selling, General and Administrative Expenses | 31.4 | 32.2 | 25.4 | 8.7 | 0.7 | 0.6 |
| Research and Development Expenses | 117.0 | 175.8 | 87.7 | 58.5 | 6.4 | 3.6 |
| Operating Income | (148.4) | (208.0) | (113.1) | (67.1) | (7.0) | (4.2) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 99 K | 0.4 | 0.1 |
| Total Other Income | 13.3 | 15.0 | 4.7 | (16.6) | (21.1) | (0.1) |
| Pre-Tax Income | (135.1) | (193.0) | (108.4) | (83.7) | (28.2) | (4.3) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (0.5) | (5.4) | 0.4 | 0.1 |
| Net Income | (135.1) | (193.0) | (108.0) | (78.4) | (28.5) | (4.5) |
| EPS | 1.97 | 3.3 | 2.06 | 1.55 | 0.57 | 0.0889 |